BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18837075)

  • 1. Methodological quality of pharmacogenetic studies: issues of concern.
    Jorgensen AL; Williamson PR
    Stat Med; 2008 Dec; 27(30):6547-69. PubMed ID: 18837075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review on the design and reporting of studies on drug-gene interaction.
    Smits KM; Schouten JS; Smits LJ; Stelma FF; Nelemans P; Prins MH
    J Clin Epidemiol; 2005 Jul; 58(7):651-4. PubMed ID: 15939214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common statistical issues in genome-wide association studies: a review on power, data quality control, genotype calling and population structure.
    Teo YY
    Curr Opin Lipidol; 2008 Apr; 19(2):133-43. PubMed ID: 18388693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designing pharmacogenetic projects in industry: practical design perspectives from the Industry Pharmacogenomics Working Group.
    Bromley CM; Close S; Cohen N; Favis R; Fijal B; Gheyas F; Liu W; Lopez-Correa C; Prokop A; Singer JB; Snapir A; Tchelet A; Wang D; Goldstaub D;
    Pharmacogenomics J; 2009 Feb; 9(1):14-22. PubMed ID: 18794908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methodological and statistical issues in pharmacogenomics.
    Peters BJ; Rodin AS; de Boer A; Maitland-van der Zee AH
    J Pharm Pharmacol; 2010 Feb; 62(2):161-6. PubMed ID: 20487194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case-control genetic association studies in gastrointestinal disease: review and recommendations.
    Saito YA; Talley NJ; de Andrade M; Petersen GM
    Am J Gastroenterol; 2006 Jun; 101(6):1379-89. PubMed ID: 16771964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics in solid organ transplantation: current status and future directions.
    de Jonge H; Kuypers DR
    Transplant Rev (Orlando); 2008 Jan; 22(1):6-20. PubMed ID: 18631854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetic analysis of clinically relevant genetic polymorphisms.
    McLeod HL
    Clin Infect Dis; 2005 Nov; 41 Suppl 7():S449-52. PubMed ID: 16237646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein therapeutics: new applications for pharmacogenetics.
    Krejsa C; Rogge M; Sadee W
    Nat Rev Drug Discov; 2006 Jun; 5(6):507-21. PubMed ID: 16763661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics in clinical practice: considerations for testing.
    Constable S; Johnson MR; Pirmohamed M
    Expert Rev Mol Diagn; 2006 Mar; 6(2):193-205. PubMed ID: 16512779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetic studies in depression: a proposal for methodologic guidelines.
    Serretti A; Kato M; Kennedy JL
    Pharmacogenomics J; 2008 Apr; 8(2):90-100. PubMed ID: 17684474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methodological quality in pharmacogenetic studies with binary assessment of treatment response: a review.
    Cobos A; Sánchez P; Aguado J; Carrasco JL
    Pharmacogenet Genomics; 2011 May; 21(5):243-50. PubMed ID: 21301379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methodological issues in genetic association studies of inherited thrombophilia: original report of recent practice.
    Simundic AM; Nikolac N; Topic E
    Clin Appl Thromb Hemost; 2009; 15(3):327-33. PubMed ID: 18387985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing quality of reports on randomized clinical trials in nursing journals.
    Parent N; Hanley JA
    Can J Cardiovasc Nurs; 2009; 19(2):25-39. PubMed ID: 19517902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Planning a cluster randomized controlled trial: methodological issues.
    Christie J; O'Halloran P; Stevenson M
    Nurs Res; 2009; 58(2):128-34. PubMed ID: 19289934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confounding in genetic association studies and its solutions.
    Hu D; Ziv E
    Methods Mol Biol; 2008; 448():31-9. PubMed ID: 18370229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The PharmGKB: integration, aggregation, and annotation of pharmacogenomic data and knowledge.
    Hodge AE; Altman RB; Klein TE
    Clin Pharmacol Ther; 2007 Jan; 81(1):21-4. PubMed ID: 17185992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
    Manchikanti L; Datta S; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genetics of human drug response.
    Goldstein DB
    Philos Trans R Soc Lond B Biol Sci; 2005 Aug; 360(1460):1571-2. PubMed ID: 16096105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Affymetrix DMET platform and pharmacogenetics in drug development.
    Deeken J
    Curr Opin Mol Ther; 2009 Jun; 11(3):260-8. PubMed ID: 19479659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.